Home>Topics>Funds>PIMCO Municipal Income II

PIMCO Municipal Income II PML

  1. All
  2. Commentary
  3. Headlines
    1. NEV


      Tue, 27 Jan 2015

      of dividends.Other muni CEF's are also rising, especially PML . VKI is up but not as much. I also own those two. Sentiment ..... the money after the sale. I don't think I would redeploy in PML or VKI at current prices. The only reason I am selling (maybe

    2. Check my understanding - muni earned income, re PML


      Wed, 21 Jan 2015

      From the PIMCO website for PML (except I added the dates): PML , NII = $0.47, UNII= $0.47(1), Distribution ..... difference between six mo average and current. CEFConnect has PML underearning as of 5/31/2014. Comments appreciated

    3. Muni CEF Breakout


      Wed, 7 Jan 2015

      Looking at a number of charts ( PML ) it looks like muni cefs are about to break out to the upside.

    4. January Holdings


      Thu, 1 Jan 2015

      start this, but Mrs. Cod has told me to "get that portfolio STUFF out of the dining room!" so before I put it away: Muni: PML , NEV*, VKI Pref: HPS*, JPS*, FPF Other: KYN, PCM, PDI, PFL, PFN, PCI, PCN, PKO, DSL, DMO, BGH *positions

    5. Current Holdings -- December


      Sat, 6 Dec 2014

      other recent changes in this category -- none) Munis ( 8% of total portfolio): KTF, MMU, MYD, BBK, NEV, BSD, BFK, PML (recent changes in this category -- none) Preferred ( 2% of total portfolio): JPI (sold a little), HPS (sold majority

    6. Muni CEFs


      Mon, 17 Nov 2014

      Considering KTF and NEV, forum favorites. I have noticed KTF down 8 days in a row, and it is on my short list of possibles, thinking it may have a better relative value. Already own PML . Opinions on adding to Muni CEFs at this time? TIA, Rick

    7. CEF Yields When Rates Peaked


      Sat, 15 Nov 2014

      22 PFN. Mult. 9.10. 8.82 PCN. Mult. 8.38. 8.47 ESD. Gl/EM. 8.21 7.64 EHI. Gl/EM. 9.79. 8.10 PML . Muni. 6.60. 6.10 BFK. Muni. 6.44. 6.14 HIX. Junk. 9.53. 8.48 My conclusions: 1) CEFs may not end up tanking

    8. Discrepency w/ Fidelity reporting


      Mon, 10 Nov 2014

      discrepency in reporting: pko -.33 vs. market's -.14 pcn -.07 vs. market's +.04 pty -.11 vs. markets's +.02 pml -.04 vs. markets's +.03 I can't think of what is going on. Any ideas? The rest of my holdings match w/ the market

    9. UPDATE 4-Biogen's Tecfidera sales miss estimates; confirms first PML case


      Wed, 22 Oct 2014

      Oct 22 (Reuters) - Biogen Idec Inc said on Wednesday sales of its big-selling new multiple sclerosis drug Tecfidera fell short of Wall Street's lofty expectations, and the company confirmed a serious...

    10. Biogen's Tecfidera Safety Fears Overblown, but Highlight a Real Life Cycle Management Risk


      Wed, 22 Oct 2014

      previous forecast of almost $3.2 billion in global sales of the drug this year. In addition, Biogen reported the first case of PML in a Tecfidera patient, who died after complications from pneumonia. We don't think this changes the risk profile of the

    « Prev12345Next »
    Content Partners